Irlanda - inglês - HPRA (Health Products Regulatory Authority)

takeda pharma a/s - dexlansoprazole - capsules modified release - 30 milligram

Cingapura - inglês - HSA (Health Sciences Authority)

apex pharma marketing pte. ltd. - paracetamol - infusion, solution - 10 mg/ml - paracetamol 10 mg/ml

Malta - inglês - Malta Medicines Authority

pharmacare srl via marghera, 29 20149, milan, italy - cilostazol - tablet - cilostazol 100 mg - antithrombotic agents

Malta - inglês - Malta Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - ramipril - tablet - ramipril 5 mg - agents acting on the renin-angiotensin system

Malta - inglês - Malta Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - ramipril - tablet - ramipril 10 mg - agents acting on the renin-angiotensin system

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

ntc srl - latanoprost - eye drops, solution - 50 microgram(s)/millilitre - prostaglandin analogues1); latanoprost

União Europeia - inglês - EMA (European Medicines Agency)

astrazeneca ab - exenatide - diabetes mellitus, type 2 - drugs used in diabetes - byetta is indicated for treatment of type-2 diabetes mellitus in combination with:metformin;sulphonylureas;thiazolidinediones;metformin and a sulphonylurea;metformin and a thiazolidinedione;in adults who have not achieved adequate glycaemic control on maximally tolerated doses of these oral therapies. byetta is also indicated as adjunctive therapy to basal insulin with or without metformin and / or pioglitazone in adults who have not achieved adequate glycaemic control with these agents.

União Europeia - inglês - EMA (European Medicines Agency)

astrazeneca ab - roflumilast - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - daliresp is indicated for maintenance treatment of severe chronic obstructive pulmonary disease (copd) (fev1 post-bronchodilator less than 50% predicted) associated with chronic bronchitis in adult patients with a history of frequent exacerbations as add-on to bronchodilator treatment.

União Europeia - inglês - EMA (European Medicines Agency)

astrazeneca ab - roflumilast - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - daxas is indicated for maintenance treatment of severe chronic obstructive pulmonary disease (copd) (fev1 post-bronchodilator less than 50% predicted) associated with chronic bronchitis in adult patients with a history of frequent exacerbations as add-on to bronchodilator treatment.,

União Europeia - inglês - EMA (European Medicines Agency)

pacira limited - cytarabine - meningeal neoplasms - antineoplastic agents, - intrathecal treatment of lymphomatous meningitis. in the majority of patients such treatment will be part of symptomatic palliation of the disease.